 | • レポートコード：D005-00026 • 出版社/出版日：GlobalInfoResearch / 2020年5月29日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、急性虚血性脳卒中診断及び治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。急性虚血性脳卒中診断及び治療の種類別市場規模（コンピュータ断層撮影（CT）、磁気共鳴画像（MRI）、頸動脈超音波、脳血管造影、心電図検査、心エコー検査、その他）、用途別市場規模（組織プラスミノーゲン活性剤、抗凝固剤、抗血小板剤、降圧剤）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Abbott、Stryker、Cordis、Medtronic、Siemens、Boston Scientific、Merck、GE Healthcare、Philips、Genentech ・地域別グローバル市場分析 2015年-2020年 ・急性虚血性脳卒中診断及び治療の北米市場（アメリカ、カナダ、メキシコ） ・急性虚血性脳卒中診断及び治療のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・急性虚血性脳卒中診断及び治療のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・急性虚血性脳卒中診断及び治療の南米市場（ブラジル、アルゼンチン） ・急性虚血性脳卒中診断及び治療の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：コンピュータ断層撮影（CT）、磁気共鳴画像（MRI）、頸動脈超音波、脳血管造影、心電図検査、心エコー検査、その他 ・用途別分析：組織プラスミノーゲン活性剤、抗凝固剤、抗血小板剤、降圧剤 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Acute Ischemic Stroke Diagnosis and Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.2% in the forecast period of 2020 to 2025 and will expected to reach USD 1225.3 million by 2025, from USD 1080.2 million in 2019.
The Acute Ischemic Stroke Diagnosis and Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Acute Ischemic Stroke Diagnosis and Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Acute Ischemic Stroke Diagnosis and Treatment market has been segmented into:
Computed Tomography (CT)
Magnetic resonance imaging (MRI)
Carotid Ultrasound
Cerebral Angiography
Electrocardiography
Echocardiography
Others
By Application, Acute Ischemic Stroke Diagnosis and Treatment has been segmented into:
Tissue Plasminogen Activator
Anticoagulant
Antiplatelet
Antihypertensive
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Acute Ischemic Stroke Diagnosis and Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level Acute Ischemic Stroke Diagnosis and Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Acute Ischemic Stroke Diagnosis and Treatment market.
The report offers in-depth assessment of the growth and other aspects of the Acute Ischemic Stroke Diagnosis and Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Acute Ischemic Stroke Diagnosis and Treatment Market Share Analysis
Acute Ischemic Stroke Diagnosis and Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Acute Ischemic Stroke Diagnosis and Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Acute Ischemic Stroke Diagnosis and Treatment sales, revenue and market share for each player covered in this report.
The major players covered in Acute Ischemic Stroke Diagnosis and Treatment are:
Abbott
Stryker
Cordis
Medtronic
Siemens
Boston Scientific
Merck
GE Healthcare
Philips
Genentech
Table of Contents
1 Acute Ischemic Stroke Diagnosis and Treatment Market Overview
1.1 Product Overview and Scope of Acute Ischemic Stroke Diagnosis and Treatment
1.2 Classification of Acute Ischemic Stroke Diagnosis and Treatment by Type
1.2.1 Global Acute Ischemic Stroke Diagnosis and Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Acute Ischemic Stroke Diagnosis and Treatment Revenue Market Share by Type in 2019
1.2.3 Computed Tomography (CT)
1.2.4 Magnetic resonance imaging (MRI)
1.2.5 Carotid Ultrasound
1.2.6 Cerebral Angiography
1.2.7 Electrocardiography
1.2.8 Echocardiography
1.2.9 Others
1.3 Global Acute Ischemic Stroke Diagnosis and Treatment Market by Application
1.3.1 Overview: Global Acute Ischemic Stroke Diagnosis and Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Tissue Plasminogen Activator
1.3.3 Anticoagulant
1.3.4 Antiplatelet
1.3.5 Antihypertensive
1.4 Global Acute Ischemic Stroke Diagnosis and Treatment Market by Regions
1.4.1 Global Acute Ischemic Stroke Diagnosis and Treatment Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Acute Ischemic Stroke Diagnosis and Treatment (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Acute Ischemic Stroke Diagnosis and Treatment Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Acute Ischemic Stroke Diagnosis and Treatment Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Acute Ischemic Stroke Diagnosis and Treatment Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Acute Ischemic Stroke Diagnosis and Treatment Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Acute Ischemic Stroke Diagnosis and Treatment Status and Prospect (2015-2025)
2 Company Profiles
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Abbott SWOT Analysis
2.1.4 Abbott Product and Services
2.1.5 Abbott Acute Ischemic Stroke Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.2 Stryker
2.2.1 Stryker Details
2.2.2 Stryker Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Stryker SWOT Analysis
2.2.4 Stryker Product and Services
2.2.5 Stryker Acute Ischemic Stroke Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.3 Cordis
2.3.1 Cordis Details
2.3.2 Cordis Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Cordis SWOT Analysis
2.3.4 Cordis Product and Services
2.3.5 Cordis Acute Ischemic Stroke Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.4 Medtronic
2.4.1 Medtronic Details
2.4.2 Medtronic Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Medtronic SWOT Analysis
2.4.4 Medtronic Product and Services
2.4.5 Medtronic Acute Ischemic Stroke Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.5 Siemens
2.5.1 Siemens Details
2.5.2 Siemens Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Siemens SWOT Analysis
2.5.4 Siemens Product and Services
2.5.5 Siemens Acute Ischemic Stroke Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.6 Boston Scientific
2.6.1 Boston Scientific Details
2.6.2 Boston Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Boston Scientific SWOT Analysis
2.6.4 Boston Scientific Product and Services
2.6.5 Boston Scientific Acute Ischemic Stroke Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.7 Merck
2.7.1 Merck Details
2.7.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Merck SWOT Analysis
2.7.4 Merck Product and Services
2.7.5 Merck Acute Ischemic Stroke Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.8 GE Healthcare
2.8.1 GE Healthcare Details
2.8.2 GE Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 GE Healthcare SWOT Analysis
2.8.4 GE Healthcare Product and Services
2.8.5 GE Healthcare Acute Ischemic Stroke Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.9 Philips
2.9.1 Philips Details
2.9.2 Philips Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Philips SWOT Analysis
2.9.4 Philips Product and Services
2.9.5 Philips Acute Ischemic Stroke Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.10 Genentech
2.10.1 Genentech Details
2.10.2 Genentech Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Genentech SWOT Analysis
2.10.4 Genentech Product and Services
2.10.5 Genentech Acute Ischemic Stroke Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Acute Ischemic Stroke Diagnosis and Treatment Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Acute Ischemic Stroke Diagnosis and Treatment Players Market Share
3.2.2 Top 10 Acute Ischemic Stroke Diagnosis and Treatment Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Acute Ischemic Stroke Diagnosis and Treatment Revenue and Market Share by Regions
4.2 North America Acute Ischemic Stroke Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
4.3 Europe Acute Ischemic Stroke Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Acute Ischemic Stroke Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
4.5 South America Acute Ischemic Stroke Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Acute Ischemic Stroke Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
5 North America Acute Ischemic Stroke Diagnosis and Treatment Revenue by Countries
5.1 North America Acute Ischemic Stroke Diagnosis and Treatment Revenue by Countries (2015-2020)
5.2 USA Acute Ischemic Stroke Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
5.3 Canada Acute Ischemic Stroke Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
5.4 Mexico Acute Ischemic Stroke Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
6 Europe Acute Ischemic Stroke Diagnosis and Treatment Revenue by Countries
6.1 Europe Acute Ischemic Stroke Diagnosis and Treatment Revenue by Countries (2015-2020)
6.2 Germany Acute Ischemic Stroke Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
6.3 UK Acute Ischemic Stroke Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
6.4 France Acute Ischemic Stroke Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
6.5 Russia Acute Ischemic Stroke Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
6.6 Italy Acute Ischemic Stroke Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Acute Ischemic Stroke Diagnosis and Treatment Revenue by Countries
7.1 Asia-Pacific Acute Ischemic Stroke Diagnosis and Treatment Revenue by Countries (2015-2020)
7.2 China Acute Ischemic Stroke Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
7.3 Japan Acute Ischemic Stroke Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
7.4 Korea Acute Ischemic Stroke Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
7.5 India Acute Ischemic Stroke Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Acute Ischemic Stroke Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
8 South America Acute Ischemic Stroke Diagnosis and Treatment Revenue by Countries
8.1 South America Acute Ischemic Stroke Diagnosis and Treatment Revenue by Countries (2015-2020)
8.2 Brazil Acute Ischemic Stroke Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
8.3 Argentina Acute Ischemic Stroke Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Acute Ischemic Stroke Diagnosis and Treatment by Countries
9.1 Middle East & Africa Acute Ischemic Stroke Diagnosis and Treatment Revenue by Countries (2015-2020)
9.2 Saudi Arabia Acute Ischemic Stroke Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
9.3 UAE Acute Ischemic Stroke Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
9.4 Egypt Acute Ischemic Stroke Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
9.5 South Africa Acute Ischemic Stroke Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Acute Ischemic Stroke Diagnosis and Treatment Revenue and Market Share by Type (2015-2020)
10.2 Global Acute Ischemic Stroke Diagnosis and Treatment Market Forecast by Type (2019-2024)
10.3 Computed Tomography (CT) Revenue Growth Rate (2015-2025)
10.4 Magnetic resonance imaging (MRI) Revenue Growth Rate (2015-2025)
10.5 Carotid Ultrasound Revenue Growth Rate (2015-2025)
10.6 Cerebral Angiography Revenue Growth Rate (2015-2025)
10.7 Electrocardiography Revenue Growth Rate (2015-2025)
10.8 Echocardiography Revenue Growth Rate (2015-2025)
10.9 Others Revenue Growth Rate (2015-2025)
11 Global Acute Ischemic Stroke Diagnosis and Treatment Market Segment by Application
11.1 Global Acute Ischemic Stroke Diagnosis and Treatment Revenue Market Share by Application (2015-2020)
11.2 Acute Ischemic Stroke Diagnosis and Treatment Market Forecast by Application (2019-2024)
11.3 Tissue Plasminogen Activator Revenue Growth (2015-2020)
11.4 Anticoagulant Revenue Growth (2015-2020)
11.5 Antiplatelet Revenue Growth (2015-2020)
11.6 Antihypertensive Revenue Growth (2015-2020)
12 Global Acute Ischemic Stroke Diagnosis and Treatment Market Size Forecast (2021-2025)
12.1 Global Acute Ischemic Stroke Diagnosis and Treatment Market Size Forecast (2021-2025)
12.2 Global Acute Ischemic Stroke Diagnosis and Treatment Market Forecast by Regions (2021-2025)
12.3 North America Acute Ischemic Stroke Diagnosis and Treatment Revenue Market Forecast (2021-2025)
12.4 Europe Acute Ischemic Stroke Diagnosis and Treatment Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Acute Ischemic Stroke Diagnosis and Treatment Revenue Market Forecast (2021-2025)
12.6 South America Acute Ischemic Stroke Diagnosis and Treatment Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Acute Ischemic Stroke Diagnosis and Treatment Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Acute Ischemic Stroke Diagnosis and Treatment Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Acute Ischemic Stroke Diagnosis and Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Acute Ischemic Stroke Diagnosis and Treatment Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Acute Ischemic Stroke Diagnosis and Treatment Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Abbott Corporate Information, Location and Competitors
Table 6. Abbott Acute Ischemic Stroke Diagnosis and Treatment Major Business
Table 7. Abbott Acute Ischemic Stroke Diagnosis and Treatment Total Revenue (USD Million) (2017-2018)
Table 8. Abbott SWOT Analysis
Table 9. Abbott Acute Ischemic Stroke Diagnosis and Treatment Product and Solutions
Table 10. Abbott Acute Ischemic Stroke Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Stryker Corporate Information, Location and Competitors
Table 12. Stryker Acute Ischemic Stroke Diagnosis and Treatment Major Business
Table 13. Stryker Acute Ischemic Stroke Diagnosis and Treatment Total Revenue (USD Million) (2018-2019)
Table 14. Stryker SWOT Analysis
Table 15. Stryker Acute Ischemic Stroke Diagnosis and Treatment Product and Solutions
Table 16. Stryker Acute Ischemic Stroke Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Cordis Corporate Information, Location and Competitors
Table 18. Cordis Acute Ischemic Stroke Diagnosis and Treatment Major Business
Table 19. Cordis Acute Ischemic Stroke Diagnosis and Treatment Total Revenue (USD Million) (2017-2018)
Table 20. Cordis SWOT Analysis
Table 21. Cordis Acute Ischemic Stroke Diagnosis and Treatment Product and Solutions
Table 22. Cordis Acute Ischemic Stroke Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Medtronic Corporate Information, Location and Competitors
Table 24. Medtronic Acute Ischemic Stroke Diagnosis and Treatment Major Business
Table 25. Medtronic Acute Ischemic Stroke Diagnosis and Treatment Total Revenue (USD Million) (2017-2018)
Table 26. Medtronic SWOT Analysis
Table 27. Medtronic Acute Ischemic Stroke Diagnosis and Treatment Product and Solutions
Table 28. Medtronic Acute Ischemic Stroke Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Siemens Corporate Information, Location and Competitors
Table 30. Siemens Acute Ischemic Stroke Diagnosis and Treatment Major Business
Table 31. Siemens Acute Ischemic Stroke Diagnosis and Treatment Total Revenue (USD Million) (2017-2018)
Table 32. Siemens SWOT Analysis
Table 33. Siemens Acute Ischemic Stroke Diagnosis and Treatment Product and Solutions
Table 34. Siemens Acute Ischemic Stroke Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Boston Scientific Corporate Information, Location and Competitors
Table 36. Boston Scientific Acute Ischemic Stroke Diagnosis and Treatment Major Business
Table 37. Boston Scientific Acute Ischemic Stroke Diagnosis and Treatment Total Revenue (USD Million) (2017-2018)
Table 38. Boston Scientific SWOT Analysis
Table 39. Boston Scientific Acute Ischemic Stroke Diagnosis and Treatment Product and Solutions
Table 40. Boston Scientific Acute Ischemic Stroke Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Merck Corporate Information, Location and Competitors
Table 42. Merck Acute Ischemic Stroke Diagnosis and Treatment Major Business
Table 43. Merck Acute Ischemic Stroke Diagnosis and Treatment Total Revenue (USD Million) (2017-2018)
Table 44. Merck SWOT Analysis
Table 45. Merck Acute Ischemic Stroke Diagnosis and Treatment Product and Solutions
Table 46. Merck Acute Ischemic Stroke Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. GE Healthcare Corporate Information, Location and Competitors
Table 48. GE Healthcare Acute Ischemic Stroke Diagnosis and Treatment Major Business
Table 49. GE Healthcare Acute Ischemic Stroke Diagnosis and Treatment Total Revenue (USD Million) (2017-2018)
Table 50. GE Healthcare SWOT Analysis
Table 51. GE Healthcare Acute Ischemic Stroke Diagnosis and Treatment Product and Solutions
Table 52. GE Healthcare Acute Ischemic Stroke Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Philips Corporate Information, Location and Competitors
Table 54. Philips Acute Ischemic Stroke Diagnosis and Treatment Major Business
Table 55. Philips Acute Ischemic Stroke Diagnosis and Treatment Total Revenue (USD Million) (2017-2018)
Table 56. Philips SWOT Analysis
Table 57. Philips Acute Ischemic Stroke Diagnosis and Treatment Product and Solutions
Table 58. Philips Acute Ischemic Stroke Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Genentech Corporate Information, Location and Competitors
Table 60. Genentech Acute Ischemic Stroke Diagnosis and Treatment Major Business
Table 61. Genentech Acute Ischemic Stroke Diagnosis and Treatment Total Revenue (USD Million) (2017-2018)
Table 62. Genentech SWOT Analysis
Table 63. Genentech Acute Ischemic Stroke Diagnosis and Treatment Product and Solutions
Table 64. Genentech Acute Ischemic Stroke Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Global Acute Ischemic Stroke Diagnosis and Treatment Revenue (Million USD) by Players (2015-2020)
Table 66. Global Acute Ischemic Stroke Diagnosis and Treatment Revenue Share by Players (2015-2020)
Table 67. Global Acute Ischemic Stroke Diagnosis and Treatment Revenue (Million USD) by Regions (2015-2020)
Table 68. Global Acute Ischemic Stroke Diagnosis and Treatment Revenue Market Share by Regions (2015-2020)
Table 69. North America Acute Ischemic Stroke Diagnosis and Treatment Revenue by Countries (2015-2020)
Table 70. North America Acute Ischemic Stroke Diagnosis and Treatment Revenue Market Share by Countries (2015-2020)
Table 71. Europe Acute Ischemic Stroke Diagnosis and Treatment Revenue (Million USD) by Countries (2015-2020)
Table 72. Asia-Pacific Acute Ischemic Stroke Diagnosis and Treatment Revenue (Million USD) by Countries (2015-2020)
Table 73. South America Acute Ischemic Stroke Diagnosis and Treatment Revenue by Countries (2015-2020)
Table 74. South America Acute Ischemic Stroke Diagnosis and Treatment Revenue Market Share by Countries (2015-2020)
Table 75. Middle East and Africa Acute Ischemic Stroke Diagnosis and Treatment Revenue (Million USD) by Countries (2015-2020)
Table 76. Middle East and Africa Acute Ischemic Stroke Diagnosis and Treatment Revenue Market Share by Countries (2015-2020)
Table 77. Global Acute Ischemic Stroke Diagnosis and Treatment Revenue (Million USD) by Type (2015-2020)
Table 78. Global Acute Ischemic Stroke Diagnosis and Treatment Revenue Share by Type (2015-2020)
Table 79. Global Acute Ischemic Stroke Diagnosis and Treatment Revenue Forecast by Type (2021-2025)
Table 80. Global Acute Ischemic Stroke Diagnosis and Treatment Revenue by Application (2015-2020)
Table 81. Global Acute Ischemic Stroke Diagnosis and Treatment Revenue Share by Application (2015-2020)
Table 82. Global Acute Ischemic Stroke Diagnosis and Treatment Revenue Forecast by Application (2021-2025)
Table 83. Global Acute Ischemic Stroke Diagnosis and Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Acute Ischemic Stroke Diagnosis and Treatment Picture
Figure 2. Global Acute Ischemic Stroke Diagnosis and Treatment Revenue Market Share by Type in 2019
Figure 3. Computed Tomography (CT) Picture
Figure 4. Magnetic resonance imaging (MRI) Picture
Figure 5. Carotid Ultrasound Picture
Figure 6. Cerebral Angiography Picture
Figure 7. Electrocardiography Picture
Figure 8. Echocardiography Picture
Figure 9. Others Picture
Figure 10. Acute Ischemic Stroke Diagnosis and Treatment Revenue Market Share by Application in 2019
Figure 11. Tissue Plasminogen Activator Picture
Figure 12. Anticoagulant Picture
Figure 13. Antiplatelet Picture
Figure 14. Antihypertensive Picture
Figure 15. Global Acute Ischemic Stroke Diagnosis and Treatment Revenue (USD Million) and Growth Rate (2015-2025)
Figure 16. North America Acute Ischemic Stroke Diagnosis and Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Europe Acute Ischemic Stroke Diagnosis and Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Asia-Pacific Acute Ischemic Stroke Diagnosis and Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. South America Acute Ischemic Stroke Diagnosis and Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Middle East and Africa Acute Ischemic Stroke Diagnosis and Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Global Acute Ischemic Stroke Diagnosis and Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 22. Global Acute Ischemic Stroke Diagnosis and Treatment Revenue Share by Players in 2019
Figure 23. Global Top 5 Players Acute Ischemic Stroke Diagnosis and Treatment Revenue Market Share in 2019
Figure 24. Global Top 10 Players Acute Ischemic Stroke Diagnosis and Treatment Revenue Market Share in 2019
Figure 25. Key Players Market Share Trend
Figure 26. Global Acute Ischemic Stroke Diagnosis and Treatment Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 27. Global Acute Ischemic Stroke Diagnosis and Treatment Revenue Market Share by Regions (2015-2020)
Figure 28. Global Acute Ischemic Stroke Diagnosis and Treatment Revenue Market Share by Regions in 2018
Figure 29. North America Acute Ischemic Stroke Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
Figure 30. Europe Acute Ischemic Stroke Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
Figure 31. Asia-Pacific Acute Ischemic Stroke Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
Figure 32. South America Acute Ischemic Stroke Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
Figure 33. Middle East and Africa Acute Ischemic Stroke Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
Figure 34. North America Acute Ischemic Stroke Diagnosis and Treatment Revenue Market Share by Countries (2015-2020)
Figure 35. North America Acute Ischemic Stroke Diagnosis and Treatment Revenue Market Share by Countries in 2019
Figure 36. USA Acute Ischemic Stroke Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
Figure 37. Canada Acute Ischemic Stroke Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
Figure 38. Mexico Acute Ischemic Stroke Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
Figure 39. Europe Acute Ischemic Stroke Diagnosis and Treatment Revenue Market Share by Countries (2015-2020)
Figure 40. Europe Acute Ischemic Stroke Diagnosis and Treatment Revenue Market Share by Countries in 2019
Figure 41. Germany Acute Ischemic Stroke Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
Figure 42. UK Acute Ischemic Stroke Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
Figure 43. France Acute Ischemic Stroke Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
Figure 44. Russia Acute Ischemic Stroke Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
Figure 45. Italy Acute Ischemic Stroke Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
Figure 46. Asia-Pacific Acute Ischemic Stroke Diagnosis and Treatment Revenue Market Share by Countries (2015-2020)
Figure 47. Asia-Pacific Acute Ischemic Stroke Diagnosis and Treatment Revenue Market Share by Countries in 2019
Figure 48. China Acute Ischemic Stroke Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
Figure 49. Japan Acute Ischemic Stroke Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
Figure 50. Korea Acute Ischemic Stroke Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
Figure 51. India Acute Ischemic Stroke Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
Figure 52. Southeast Asia Acute Ischemic Stroke Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
Figure 53. South America Acute Ischemic Stroke Diagnosis and Treatment Revenue Market Share by Countries (2015-2020)
Figure 54. South America Acute Ischemic Stroke Diagnosis and Treatment Revenue Market Share by Countries in 2019
Figure 55. Brazil Acute Ischemic Stroke Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
Figure 56. Argentina Acute Ischemic Stroke Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
Figure 57. Middle East and Africa Acute Ischemic Stroke Diagnosis and Treatment Revenue Market Share by Countries (2015-2020)
Figure 58. Middle East and Africa Acute Ischemic Stroke Diagnosis and Treatment Revenue Market Share by Countries in 2019
Figure 59. Saudi Arabia Acute Ischemic Stroke Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
Figure 60. UAE Acute Ischemic Stroke Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
Figure 61. Egypt Acute Ischemic Stroke Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
Figure 62. South Africa Acute Ischemic Stroke Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
Figure 63. Global Acute Ischemic Stroke Diagnosis and Treatment Revenue Share by Type (2015-2020)
Figure 64. Global Acute Ischemic Stroke Diagnosis and Treatment Revenue Share by Type in 2019
Figure 65. Global Acute Ischemic Stroke Diagnosis and Treatment Market Share Forecast by Type (2021-2025)
Figure 66. Global Computed Tomography (CT) Revenue Growth Rate (2015-2020)
Figure 67. Global Magnetic resonance imaging (MRI) Revenue Growth Rate (2015-2020)
Figure 68. Global Carotid Ultrasound Revenue Growth Rate (2015-2020)
Figure 69. Global Cerebral Angiography Revenue Growth Rate (2015-2020)
Figure 70. Global Electrocardiography Revenue Growth Rate (2015-2020)
Figure 71. Global Echocardiography Revenue Growth Rate (2015-2020)
Figure 72. Global Others Revenue Growth Rate (2015-2020)
Figure 73. Global Acute Ischemic Stroke Diagnosis and Treatment Revenue Share by Application (2015-2020)
Figure 74. Global Acute Ischemic Stroke Diagnosis and Treatment Revenue Share by Application in 2019
Figure 75. Global Acute Ischemic Stroke Diagnosis and Treatment Market Share Forecast by Application (2021-2025)
Figure 76. Global Tissue Plasminogen Activator Revenue Growth Rate (2015-2020)
Figure 77. Global Anticoagulant Revenue Growth Rate (2015-2020)
Figure 78. Global Antiplatelet Revenue Growth Rate (2015-2020)
Figure 79. Global Antihypertensive Revenue Growth Rate (2015-2020)
Figure 80. Global Acute Ischemic Stroke Diagnosis and Treatment Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 81. Global Acute Ischemic Stroke Diagnosis and Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 82. Global Acute Ischemic Stroke Diagnosis and Treatment Revenue Market Share Forecast by Regions (2021-2025)
Figure 83. North America Acute Ischemic Stroke Diagnosis and Treatment Revenue Market Forecast (2021-2025)
Figure 84. Europe Acute Ischemic Stroke Diagnosis and Treatment Revenue Market Forecast (2021-2025)
Figure 85. Asia-Pacific Acute Ischemic Stroke Diagnosis and Treatment Revenue Market Forecast (2021-2025)
Figure 86. South America Acute Ischemic Stroke Diagnosis and Treatment Revenue Market Forecast (2021-2025)
Figure 87. Middle East and Africa Acute Ischemic Stroke Diagnosis and Treatment Revenue Market Forecast (2021-2025)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel
心房細動（SPAF）治療における脳卒中予防の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Stroke Prevention in Atrial Fibrillation (SPAF) Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million …- 脳卒中診断＆治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Stroke Diagnostics and Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.6% in the forecast period of 2020 to 2025 and will expected to reach USD 27550 million by 2025, from USD 23000 million in 2019. The St…
- 急性中耳炎治療の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Acute Otitis Media Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.8% in the forecast period of 2020 to 2025 and will expected to reach USD 2245.2 million by 2025, from USD 2013 million in 2019. The Acute Oti…
- HIV診断および治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global HIV Diagnosis and Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The HIV Diagnosis and…
- クラミジア診断＆治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Chlamydia Diagnosis and Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Chlamydia D…